Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Vu

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Diseases of the Colon and Rectum|December 27, 2024
Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal CancerJennifer K Vu, Kilian G M Brown, Michael J Solomon, et al.
The British Journal of Surgery|August 12, 2025
Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancerJennifer K Vu, Kilian G M Brown, Michael J Solomon, et al.
Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.
Nature Genetics|February 21, 2018
A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathiesDavid K Breslow, Sascha Hoogendoorn, Adam R Kopp, et al.
Acta Ophthalmologica|July 3, 2026
Three years of ocular proton therapy in the Netherlands, clinical resultsC Rasch, M Marinkovic, L Pors, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 4, 2019
Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic AgentsNguyen V Minh, Nguyen T Thanh, Hoang T Lien, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Reprogramming cell fate with a genome-scale library of artificial transcription factorsAsuka Eguchi, Matthew J Wleklinski, Mackenzie C Spurgat, et al.
Journal of Extracellular Vesicles|October 19, 2021
Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivoMiriam Bittel, Patrick Reichert, Ilann Sarfati, et al.
Clinical and Translational Radiation Oncology|March 20, 2025
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanomaL J Pors, M Marinkovic, H H Deuzeman, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Diseases of the Colon and Rectum|December 27, 2024
Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal CancerJennifer K Vu, Kilian G M Brown, Michael J Solomon, et al.
The British Journal of Surgery|August 12, 2025
Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancerJennifer K Vu, Kilian G M Brown, Michael J Solomon, et al.
Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.
Nature Genetics|February 21, 2018
A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathiesDavid K Breslow, Sascha Hoogendoorn, Adam R Kopp, et al.
Acta Ophthalmologica|July 3, 2026
Three years of ocular proton therapy in the Netherlands, clinical resultsC Rasch, M Marinkovic, L Pors, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 4, 2019
Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic AgentsNguyen V Minh, Nguyen T Thanh, Hoang T Lien, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Reprogramming cell fate with a genome-scale library of artificial transcription factorsAsuka Eguchi, Matthew J Wleklinski, Mackenzie C Spurgat, et al.
Journal of Extracellular Vesicles|October 19, 2021
Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivoMiriam Bittel, Patrick Reichert, Ilann Sarfati, et al.
Clinical and Translational Radiation Oncology|March 20, 2025
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanomaL J Pors, M Marinkovic, H H Deuzeman, et al.
Pageof 18